Research of Intensive Treatment in Hormone Receptor<10% and Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer Patients With Positive Lymph Node Residual Disease After Neoadjuvant Chemotherapy
Clinical trial NCT03270007 · UNKNOWN
Trial details
- NCT number
- NCT03270007
- Sponsor
- Tao OUYANG
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-10
- Primary completion
- 2024-06-30
- Enrollment
- 304
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.